Manorama Industries Approves Subsidiary Capital Infusions and Board Appointments
Manorama Industries Ltd · Outcome · 05 Sept 2026, 1:51 am
Manorama Industries Approves Subsidiary Capital Infusions and Board Appointments Manorama Industries' board approved capital infusions totaling up to ₹75 crore across six wholly owned overseas subsidiaries on 4th Sep'26. Allocations include up to ₹20 crore for Ghana, ₹15 crore each for Burkina Faso and Brazil, ₹10 crore each for Nigeria and Chad, and ₹5 crore for UAE to fund working capital and operations. Additionally, the board appointed Dr. Rohini Tiwari as Non-Executive Independent Director for five years effective 4th Sep'26, while noting the tenure completion of Independent Director Mr. Mudit Kumar Singh on 5th Sep'26.
Original exchange filing (PDF)
More announcements from Manorama Industries Ltd
- Transcript of Q2 & H1 FY27 Earnings Conference Call held on Friday, November 13, 2026. · 17 Nov 2026
- Intimation of Investor meet scheduled to be held on Wednesday, November 18, 2026. · 13 Nov 2026
- Intimation of Audio recording of the Q2 & H1 FY27 Earnings Conference Call with Analyst /Investors held on Friday, November 13, 2026 · 13 Nov 2026
- Investor Presentation · 13 Nov 2026
- Press Release · 13 Nov 2026
- Monitoring Agency Report · 13 Nov 2026
- Statement of Deviation and Variation · 13 Nov 2026
- Outcome of Board Meeting dated November 12, 2026 · 13 Nov 2026
